Clobetasol Use on the Breast

Appropriate Use Guidelines

The American Academy of Dermatology recommends clobetasol propionate as an ultra-high potency (class 1) topical corticosteroid that can be used on breast skin for dermatological conditions 1
Once daily application of clobetasol propionate is typically sufficient for therapeutic effect, as pharmacodynamic studies show ultrapotent corticosteroids only need once daily application 2, 1
Treatment should be limited to 2-4 weeks of continuous use to prevent adverse effects, with a tapering schedule recommended after the initial treatment period 1

For lichen sclerosus affecting the breast, the recommended regimen is clobetasol propionate 0.05% once daily for 4 weeks, then alternate nights for 4 weeks, and finally twice weekly for 4 weeks, with maintenance therapy as needed for flares 1, 2, 3
For bullous pemphigoid with localized lesions on the breast, apply 10-20g of clobetasol propionate daily to lesional skin only, with up to 30g daily required for extensive disease 4, 1

Common local adverse effects of clobetasol propionate include skin atrophy, striae, folliculitis, telangiectasia, and purpura, with the breast area at risk for developing adverse effects due to potential occlusion and thinner skin in certain areas 1

Apply a thin layer of clobetasol propionate to affected areas only, avoiding application to unaffected skin to minimize risk of adverse effects 1
A 30g tube of clobetasol propionate should last approximately 12 weeks when used as recommended, with patients advised to use a soap substitute in the affected area to prevent irritation 2, 3, 5